Understanding Our Shifting Health Insurance Landscape – and What It Means for People with Vision Loss

Guest blogger Rebecca Sheffield, Ph.D., is the Senior Policy Researcher with the American Foundation for the Blind (AFB) Public Policy Center in Washington, D.C. The AFB Public Policy Center collaborates with policy makers in Congress and the Executive Branch to ensure that Americans with vision loss have equal rights and opportunities to fully participate in … Continued

Understanding Our Shifting Health Insurance Landscape – and What It Means for People with Vision Loss

Guest blogger Rebecca Sheffield, Ph.D., is the Senior Policy Researcher with the American Foundation for the Blind (AFB) Public Policy Center in Washington, D.C. The AFB Public Policy Center collaborates with policy makers in Congress and the Executive Branch to ensure that Americans with vision loss have equal rights and opportunities to fully participate in … Continued

Readers Beware: In a Dangerous and Unregulated Stem Cell Treatment, Patients Lose Sight After Stem Cells Are Injected Into Their Eyes

Of all the eye research developments reported on the VisionAware blog, it is stem cell research for eye disease that generates the most inquiries from our readers. Many readers request information about stem cells, assuming that this is an established and widely-performed treatment for eye disease; others ask for help in finding a doctor who … Continued

New Research: Gene Editing as a Potential Treatment for Wet Macular Degeneration

At present, there are a number of current treatments for wet age-related macular degeneration, including the drugs Lucentis, Eylea, and Avastin, administered by injection with a very small needle directly into the eye after the surface has been numbed. There have also been a number of treatments that have proven to be inconclusive or unsuccessful … Continued

New Macular Degeneration Research: Will My AMD Affect Both Eyes? If So, How Soon Will That Happen?

Two questions asked most frequently by readers about age-related macular degeneration (AMD) involve (a) individual risk for the disorder and (b) the likelihood of eventual involvement of both eyes. In response, several recent studies have attempted to address these critically important questions: Data from the ongoing Blue Mountains Eye Study (BMES) and the Age-Related Eye … Continued

Clinical Trial Update: Squalamine Eye Drops for Wet Macular Degeneration

Many readers have been following closely the development of Squalamine Eye Drops for wet age-related macular degeneration, hoping that a self-administered at-home eye drop could reduce, or even eliminate, the need for monthly or as-needed eye injections. Unfortunately, a clinical trial designed to test this concept has produced disappointing results: Squalamine Eye Drops failed to … Continued

New Research: Ebola Survivors Have Ongoing Risk of Eye Disease, Even When the Initial Outbreak Has Concluded

Although worldwide attention was focused on the 2014-2016 Ebola outbreak in West Africa, considerably less attention – until now – has been paid to the eye and vision complications resulting from the disease. This month, a group of researchers from the United States, Liberia, and Uganda have published data describing the ocular findings, visual impairment, … Continued

New Glaucoma Research from the United Kingdom: Could a Glaucoma Treatment also Help Prevent Alzheimer’s Disease?

Two recent United Kingdom-based eye research projects have begun to explore potential (but not yet proven) links between retinal disease and beta-amyloid proteins that accumulate in the brains of people with Alzheimer’s disease. The first project, from the University of Southampton, England, investigated the potential role of beta-amyloid protein in the development of macular degeneration. … Continued

January Is National Glaucoma Awareness Month: Learn More About Glaucoma and Current Treatments

National Glaucoma Awareness Month provides a perfect opportunity to learn more about glaucoma, a leading cause of vision loss that affects more than 3 million people in the United States. Glaucoma often is called “the sneak thief of sight” for good reason: Many people are unaware that glaucoma has few symptoms or warning signs in … Continued

Our Readers Want to Know: What Is the Progress of Stem Cell Research for Eye Disease? Answer: It Has a Very Long Way to Go

Of all the eye research developments reported on the VisionAware blog, it is stem cell research for eye disease that generates the most inquiries from readers. Many readers request information about how to join a stem cell clinical trial, or find a doctor who will perform stem cell treatments. In response to these inquiries, my … Continued